DUBLIN–(BUSINESS WIRE)–The “EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033” report has been added to ResearchAndMarkets.com’s offering.
Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. Secondary sources estimate that approximately 2 million new cases of lung cancer were reported worldwide in 2018. Cigarette smoking is the dominant risk factor associated with lung cancer across all age groups, with approximately 80% of male and 45% of female lung cancer cases worldwide attributed to smoking.
EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating cellular proliferation, invasion, metastasis, angiogenesis, and inhibition of apoptosis. EGFR is one of the most routinely tested biomarker in NSCLC.
Most EGFR mutations found in adenocarcinoma are located in the tyrosine kinase domain. The most frequently encountered mutations are in-frame deletions in exon 19 (around 45%) and a point mutation in exon 21 (L858R), which together account for over 85% of described mutations. These mutations strongly correlate with NSCLC patients responding to EGFR therapies such as the tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib, afatinib, and icotinib.
The model includes EGFR Immunohistochemistry Tests, EGFR Sanger Sequencing Tests, EGFR Nucleic Acid Amplification Tests (NAATs), and EGFR Other Tests (EGFR ISH and Mass Array tests).
Key Inclusions of the market model are:
Currently marketed EGFR Tests and evolving competitive landscape:
Insightful review of the key industry trends.
Annualized total EGFR Tests market revenue by segment and market outlooks from 2015-2033.
Market level data on units, average selling prices and market values.
Global, Regional and Country level market specific insights:
Qualitative market specific information is available with global trends further broken down into regional trends. In addition, the publisher analysts provide unique country specific insights on the market.
SWOT analysis for EGFR Tests market.
Competitive dynamics insights and trends provided for EGFR Tests market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Country specific overview of the healthcare system.
Country specific reimbursement policies.
Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Company Coverage:
F. Hoffmann-La Roche
Qiagen
Agilent Technologies
Illumina
Thermo Fisher Scientific
Abbott Laboratories
NimaGen
Mesa Laboratories
New England Biolabs
Amoy Diagnostics
Panagene
The model will enable you to:
Understand the impact of COVID-19 on EGFR Tests market.
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving EGFR Tests market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the EGFR Tests market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
Track device sales in the global and country-specific EGFR Tests market from 2015-2033.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
For more information about this report visit https://www.researchandmarkets.com/r/l65d9b
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900